The efficacy of intravenous milrinone in left ventricular restoration

Annals of Thoracic and Cardiovascular Surgery

Volumn 15, Issue 4, 2009, Pages 233-238

  Yamaguchi, Atsushi ^a   Tanaka, Masashi ^a   Naito, Kazuhiro ^a   Kimura, Chieri ^a   Kobinata, Toshiyuki ^a   Okamura, Homare ^a   Ino, Takashi ^a   Adachi, Hideo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass grafting; Inotropic agent; Left ventricular restoration

Indexed keywords

ADRENALIN; CARDIOTONIC AGENT; DOBUTAMINE; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

AGED; ARTICLE; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CONVALESCENCE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; HEART SURGERY; HEART VENTRICLE PRESSURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHIES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; DOBUTAMINE; EPINEPHRINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; MYOCARDIAL ISCHEMIA; PHOSPHODIESTERASE INHIBITORS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 70349314769     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Silver PJ. Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 1989; 63: 2-8A.
2. Rocci ML Jr, Wilson H. The pharmacokinetics and pharmacodynamics of newer inotropic agents. Clin Pharmacokinet 1987; 13: 91-109.
3. Levy JH, Ramsay J, Bailey JM Jr. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothorac Anesth 1990; 4 (Suppl 5): 7-11.
4. Harrison SA, Chang ML, Beavo JA. Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs. Circulation 1986; 73 (3 Pt 2): III109-16.
5. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 1994; 81: 616-622
6. Doolan LA, Jones EF, Kalman J, Buxton BF, Tonkin AM. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from car- diopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 37-41.
7. Butterworth JF IV, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995; 81: 783-792
8. Feneck RO. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. European Multicenter Trial Group. Am Heart J 1991; 121 (6 Pt 2): 1995-1999
9. Feneck RO. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 1992; 6: 563-567
10. Kazui T, Osada H, Fujita H; Japanese Association for Thoracic Surgery Committee for Scientific Affairs. Thoracic and cardiovascular surgery in Japan during 2004. Jpn J Thorac Cardiovasc Surg 2006; 54: 363-365
11. Athanasuleas CL, Stanley AW, Buckberg GD, Dor V, Di Donato M, et al.; RESTORE Group. Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg 2001; 13: 448-458
12. Dor V, Di Donato M, Sabatier M, Montiglio F, Civaia F; RESTORE Group. Left ventricular reconstruction by endoventricular circular patch plasty repair: a 17-year experience. Semin Thorac Cardiovasc Surg 2001; 13: 435-447
13. Möllhoff T, Schmidt C, Van Aken H, Berendes E, Buerkle H, et al. Myocardial ischemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting-milrinone versus nifedipine. Eur J Anesthesiol 2002; 19: 796-802.
14. Kikura M, Levy JH, Michelsen LG., Shanewise JS, Bailey JM, et al. The effect of milrinone on hemody- namics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 1997; 85:b 16-22.
15. Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling following acute myocardial infarction: mechanism and management. Am J Cardiol 1991; 68: 1-6D.
16. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993; 87: 755-763
17. Feldman AM, Bristow MR. The ß-adrenergic pathway in the failing heart: Implications for inotropic therapy. Cardiology 1990; 77 (Suppl): 1-32.
18. Weber KT, Janicki JS, Jain MC. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 1986; 58: 589-595